Week in Review: May 5–9

Synthetic base pairs replicated in vivo; cardiac stem cells questioned; miniature neurotransmissions and synaptic development; neurogenesis and memory loss; STAP saga continues

Written byTracy Vence
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

SYNTHORXInvestigators at The Scripps Research Institute in La Jolla, California, have created and introduced into Escherichia coli a synthetic nitrogenous base pair that replicated within the bacteria, advancing a long-sought goal in the field—creating cells capable of producing proteins with synthetic DNA elements. Their work was published in Nature this week (May 7).

“This is the first paper to show the possibility that living organisms can have really artificial DNA with [an] expanded genetic alphabet,” Ichiro Hirao, a synthetic biologist at the RIKEN Center for Life Science Technologies in Japan who was not involved in the work, told The Scientist in an e-mail.

WIKIMEDIA, BIOMED CENTRAL; SÁNCHEZ-SORIANO, TEAR, WHITINGTON, PROKOPOnce considered a byproduct of action potential-stimulated neurotransmission, miniature neurotransmission—or “minis,” in which presynaptic neurons spontaneously release synaptic vesicles that induce postsynaptic neuronal activity—are essential for synaptic maturation at Drosophila larval neuromuscular junction, according to a study published in Neuron this week (May 7). The work “adds to several reports over the last 10 years that have established a functional role for miniature events at synapses,” said Michael Sutton, an associate professor at the University of Michigan Molecular and Behavioral Neuroscience Institute, who was not involved in the research.

FLICKR, GEORGE SHULKINWhether c-kit cells—supposed cardiac stem cells—can help repair cardiac tissue following a heart attack is an open question, as scientists continue to review basic research results. And a study published in Nature this week (May 7) adds to mounting evidence that c-kit cells rarely produce new heart muscle in vivo.

“The conclusion I am led to from this is that the c-kit cell is not a cardiac stem cell, at least in term of its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies